HPR
Basic information
Region (hg38): 16:72063148-72077246
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 31 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 8 | 4 |
Variants in HPR
This is a list of pathogenic ClinVar variants found in the HPR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-72074289-C-G | not specified | Uncertain significance (Oct 06, 2021) | ||
16-72074293-T-G | not specified | Likely benign (Oct 06, 2021) | ||
16-72074296-C-A | not specified | Uncertain significance (Aug 28, 2021) | ||
16-72074301-C-A | not specified | Uncertain significance (Jan 10, 2023) | ||
16-72074307-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
16-72074311-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
16-72074335-T-C | not specified | Likely benign (Sep 01, 2021) | ||
16-72074337-T-G | not specified | Likely benign (Sep 01, 2021) | ||
16-72074340-C-T | not specified | Uncertain significance (Sep 14, 2021) | ||
16-72074365-G-A | not specified | Likely benign (Apr 28, 2022) | ||
16-72074365-G-C | not specified | Uncertain significance (Oct 21, 2021) | ||
16-72074370-C-T | not specified | Uncertain significance (Jun 28, 2024) | ||
16-72074371-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
16-72076321-A-G | not specified | Uncertain significance (Mar 24, 2023) | ||
16-72076332-C-G | not specified | Likely benign (Oct 26, 2021) | ||
16-72076342-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
16-72076424-G-T | Benign (Jul 31, 2018) | |||
16-72076446-T-C | not specified | Uncertain significance (May 10, 2024) | ||
16-72076477-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
16-72076479-A-C | not specified | Uncertain significance (Aug 04, 2021) | ||
16-72076505-A-T | not specified | Uncertain significance (Dec 15, 2022) | ||
16-72076510-T-C | not specified | Uncertain significance (Jul 13, 2021) | ||
16-72076568-G-T | Benign (Jul 29, 2018) | |||
16-72076578-C-G | not specified | Uncertain significance (Dec 30, 2023) | ||
16-72076587-C-T | not specified | Uncertain significance (Aug 23, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HPR | protein_coding | protein_coding | ENST00000540303 | 5 | 22624 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.46e-10 | 0.0648 | 124654 | 1 | 168 | 124823 | 0.000677 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.52 | 243 | 185 | 1.31 | 0.0000105 | 2258 |
Missense in Polyphen | 74 | 67.883 | 1.0901 | 793 | ||
Synonymous | -1.17 | 89 | 76.0 | 1.17 | 0.00000487 | 671 |
Loss of Function | -0.108 | 14 | 13.6 | 1.03 | 6.88e-7 | 163 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000454 | 0.000454 |
Ashkenazi Jewish | 0.000696 | 0.000695 |
East Asian | 0.00301 | 0.00295 |
Finnish | 0.000186 | 0.000186 |
European (Non-Finnish) | 0.000444 | 0.000441 |
Middle Eastern | 0.00301 | 0.00295 |
South Asian | 0.00128 | 0.00128 |
Other | 0.000670 | 0.000660 |
dbNSFP
Source:
- Function
- FUNCTION: Primate-specific plasma protein associated with apolipoprotein L-I (apoL-I)-containing high-density lipoprotein (HDL). This HDL particle, termed trypanosome lytic factor-1 (TLF- 1), mediates human innate immune protection against many species of African trypanosomes. Binds hemoglobin with high affinity and may contribute to the clearance of cell-free hemoglobin to allow hepatic recycling of heme iron. {ECO:0000269|PubMed:16778136}.;
- Pathway
- African trypanosomiasis - Homo sapiens (human);Vesicle-mediated transport;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors
(Consensus)
Recessive Scores
- pRec
- 0.841
Intolerance Scores
- loftool
- 0.348
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.51
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- acute inflammatory response;proteolysis;receptor-mediated endocytosis;response to organic substance;positive regulation of cell death
- Cellular component
- extracellular region;extracellular space;spherical high-density lipoprotein particle;extracellular exosome;blood microparticle
- Molecular function
- serine-type endopeptidase activity;hemoglobin binding